glp-1 and hot flashes Ozempic, Mounjaro: 6 'Hidden' Side Effects of Weight Loss Drugs Can Menopause Impact GLP-1 Receptor

How tirzepatide actually works differently Tirzepatide is a dual GIP/GLP-1 receptor agonist

doi: 10.1016/j.cgh.2024.12.017

Historically, perioperative guidelines and reviews have not advocated the discontinuation of GLP-1RAs prior to surgical procedures

Almost universally, payers ask about past and ongoing behavioral modification, such as the magnitude of calorie restriction or hours of physical activity per week

Two weeks of exenatide treatment twice daily, 1 h before morning and evening meals, significantly reduces plasma TG following these meals (50% carbohydrate, 20% protein, and 30% fat) compared to placebo but TG levels rise to similar levels as placebo following the midday meal, where no changes in post-prandial FFA concentrations are observed (Schwartz et al., 2008)

In multivariable models adjusting for age and sex, the odds of ION remained significantly higher with Wegovy compared with Ozempic, with ION risk being three times greater in men than in women